The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
BTIG analyst Marie Thibault reiterated a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of $310.00. The ...
In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...
Digital Services Analyst Fuller holds a meeting with management in Boston on February 24 hosted by BTIG. Published first on TheFly – the ultimate ...
BTIG Research analyst C. Reichardt now forecasts that the construction company will earn $1.73 per share for the quarter, down from their prior estimate of $1.79. Skip to main content Analyst Ratings ...
On Thursday, BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib ...
announced today that it will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, on Wednesday, February 12th. Rohit Ramchandani, CFO ...
February 06, 2025--(BUSINESS WIRE)--Performant Healthcare, Inc. (Nasdaq: PHLT) ("Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, ...